Cannabis derivative cannabidiol reduces seizures in severe epilepsy disorder


Cannabis derivative cannabidiol reduces seizures in severe epilepsy disorder
Orrin Devinsky, MD, director of NYU Langone’s Comprehensive Epilepsy Center, is principal investigator of the cannabidiol for drug-resistant seizures in Dravet Syndrome trial. Credit: NYU Langone

After years of anecdotal claims about its benefits, the cannabis derivative cannabidiol reduced seizure frequency by 39 percent for patients with Dravet syndrome – a rare, severe form of epilepsy – in the first large-scale

... read more at: https://medicalxpress.com/news/2017-05-cannabis-derivative-cannabidiol-seizures-severe.html